Aarti Drugs Limited (AARTIDRUGS.BO)
INR 431.25
(-0.45%)
INR 431.25
(-0.45%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.3 Billion | 1.34 Billion | 696.35 Million | 1.54 Billion | 2.5 Billion | 1.43 Billion |
| Net Income | 1.71 Billion | 2.24 Billion | 2.69 Billion | 3.69 Billion | 1.85 Billion | 1.31 Billion |
| Depreciation & Amortization | 514.5 Million | 503.2 Million | 500.48 Million | 498.83 Million | 487.53 Million | 425.62 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.02 Billion | -1.15 Billion | -1.87 Billion | -1.86 Billion | 194.92 Million | -329.76 Million |
| Other non-cash items | 45.72 Million | -248.4 Million | -630.17 Million | -779.55 Million | -27.9 Million | 24.82 Million |
| Investing Cash Flow | -2.26 Billion | -1.63 Billion | -1.48 Billion | -716.79 Million | -332.09 Million | -616.7 Million |
| Investments in PPE | -2.26 Billion | -1.64 Billion | -1.51 Billion | -881.3 Million | -479.9 Million | -742.73 Million |
| Acquisitions | 1.9 Million | 1.45 Million | 200 Thousand | 108.86 Million | 108.46 Million | 112 Million |
| Investment purchases | - | - | - | - | -108.46 Million | - |
| Sales/Maturities of investments | - | - | - | - | 26.19 Million | - |
| Other Investing Activities | -100 Thousand | 5.54 Million | 30.93 Million | 55.65 Million | 121.61 Million | 14.02 Million |
| Financing Cash Flow | -1.04 Billion | 165.4 Million | 920.25 Million | -811.29 Million | -2.15 Billion | -800.7 Million |
| Debt repayment | -222.8 Million | -613.74 Million | -68.7 Million | -349.7 Million | -1.47 Billion | -405.54 Million |
| Dividends payments | -92.67 Million | -94.01 Million | -95.07 Million | -232.05 Million | -84.66 Million | -24.28 Million |
| Common Stock Repurchased | -731.7 Million | -613.74 Million | -600 Million | - | -253.89 Million | - |
| Common Stock Issuance | - | 7.6 Million | 1.82 Billion | - | 1.47 Billion | - |
| Other Financing Activities | -133.2 Million | 1.47 Billion | -138.37 Million | -229.53 Million | -1.82 Billion | -370.87 Million |
| Accounts receivables | 1.61 Billion | -935.42 Million | -1.93 Billion | -654.19 Million | 17.31 Million | -627.19 Million |
| Accounts payables | -925.3 Million | -277.36 Million | 1.17 Billion | -314.88 Million | 964.5 Million | -24.87 Million |
| Inventory | 342.5 Million | 58.2 Million | -1.1 Billion | -891.84 Million | -786.88 Million | 317.16 Million |
| Other working capital | -925.3 Million | -6000.00 | - | - | - | 5.13 Million |
| Cash at beginning of period | 89.59 Million | 216.1 Million | 88.12 Million | 67.71 Million | 46.43 Million | 32.92 Million |
| Cash at end of period | 94.3 Million | 83.8 Million | 216.12 Million | 88.13 Million | 67.71 Million | 46.43 Million |
| Capital Expenditure | -2.26 Billion | -1.64 Billion | -1.51 Billion | -881.3 Million | -479.9 Million | -742.73 Million |
| Effect of forex changes on cash | - | 9000.00 | -2000.00 | - | - | 1.00 |
| Net cash flow / Change in cash | 4.7 Million | -132.3 Million | 127.99 Million | 20.41 Million | 21.27 Million | 13.5 Million |
| Free Cash Flow | 1.03 Billion | -304.7 Million | -823.39 Million | 667.18 Million | 2.02 Billion | 688.18 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 332.4 Million | 473.7 Million | 1.71 Billion | 366.7 Million | 395.9 Million | 478.5 Million |
| Depreciation & Amortization | - | - | 514.5 Million | 126.6 Million | 126.1 Million | 126 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 1.02 Billion | - | - | - |
| Other non-cash items | -332.4 Million | -473.7 Million | 45.72 Million | -366.7 Million | -395.9 Million | -478.5 Million |
| Investing Cash Flow | - | - | -2.26 Billion | - | - | - |
| Investments in PPE | - | - | -2.26 Billion | - | - | - |
| Acquisitions | - | - | 1.9 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -100 Thousand | - | - | - |
| Financing Cash Flow | - | - | -1.04 Billion | - | - | - |
| Debt repayment | - | - | -222.8 Million | - | - | - |
| Dividends payments | - | - | -92.67 Million | - | - | - |
| Common Stock Repurchased | - | - | -731.7 Million | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -133.2 Million | - | - | - |
| Accounts receivables | - | - | 1.61 Billion | - | - | - |
| Accounts payables | - | - | -925.3 Million | - | - | - |
| Inventory | - | - | 342.5 Million | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | 89.59 Million | 127.2 Million | -125 Million | 89.59 Million |
| Cash at end of period | - | - | 94.3 Million | 380.4 Million | 127.2 Million | 341.59 Million |
| Capital Expenditure | - | - | -2.26 Billion | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 4.7 Million | 253.2 Million | 252.2 Million | 252 Million |
| Free Cash Flow | - | - | 1.03 Billion | 253.2 Million | 252.2 Million | 252 Million |
IRRA
300214
ZEAL
NKT
WIX
BUD